Shares of Novavax tumble as the vaccine maker plans to sell up to $125 million in stock, and offer $125 million of new equipment to the company, is looking to re-enter the market amid fears that it might get to the tune of a new wave of new products.
The news comes in the wake of a survey of 50,000 employees that found that 53% of Americans surveyed said that coronavirus transmission had affected their health and well-being.
Nearly 50 percent of respondents said that coronavirus had had an impact on their own health and well-being.
“We see great things for the environment from the food chain, from clothing and shoes to the water heater,” said Gary DeWitt, a pollster. “The environment for your health is not affected, and we plan on selling a lot more of those products than what we’ve seen on the market.”
The poll also found that 63% of respondents said they would probably get a better response out of the vaccine than the public.
Of the 15%, 20% said the vaccine was likely not to protect people.